Abiopharma

Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026

ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results

Saroj Namrata 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001288

📋 Cohen Joshua B (Officer) plans to sell 8K shares of Amylyx Pharmaceuticals, Inc. (at $11.09 each, total $86K) Filed: Jan 06, 2026 | ID: 004394

📋 BOBO DONALD E JR (Officer) plans to sell 45K shares of Edwards Lifesciences Corp (at $85.66 each, total $3.9M) Filed: Jan 06, 2026 | ID: 000013

Waheed Nadia 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001286

Director POON CHRISTINE A 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

Schaeffer Orlov S Nicole 🟡 adjusted position in 54.4K shares (2 derivative) of INSMED Inc (INSM) at $177.78 ($22.6M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Heier Jeffrey S. 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001284

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

Bulis Veronica Sanchez 🔴 sold 2.1K shares of Lyell Immunopharma, Inc. (LYEL) at $38.67 Transaction Date: Dec 24, 2025 | Filing ID: 000001

📋 NEIL W PETERSON (Officer) plans to sell 5K shares of MERIT MEDICAL SYSTEMS, INC. (at $90.00 each, total $450K) Filed: Jan 06, 2026 | ID: 000166

New Form S-8 - Biomea Fusion, Inc. Filed: 2026-01-06 AccNo: 0001193125-26-004374 Size: 196 KB

New Form POS AM - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001281 Size: 22 KB